# A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

> **NCT06557161** · PHASE2 · RECRUITING · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 170 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, Adult

## Interventions

- **RADIATION:** TBI
- **RADIATION:** TMLI
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT06557161
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2029-08-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557161, "A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06557161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*